Clinical Trial Update: Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and cardiovascular efficacy of hydralazine combined with isosorbide dinitrate in patients with dialysis-dependent ESRD has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Hydralazine and isosorbide dinitrate combination (hydralazine; isosorbide dinitrate)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Chronic Hemodialysis (ESRD) | Phase 4 | Status: COMPLETED | Results posted: 2021-04-27